Showing posts with label Men's Health. Show all posts
Showing posts with label Men's Health. Show all posts

Antioxidant Supplementation May Improve Fertility in Men

A new scientific review concludes that use of antioxidant supplements by men could help improve their partner’s chances of conceiving.

Read more about this research below.

It has been suggested that between 30% to 80% of male subfertility cases are a result of damaging effects of oxidative stress on sperm. Oral supplementation with antioxidants may improve sperm quality by reducing oxidative stress.

Researchers recently reviewed 34 randomized, controlled trials that included a total of 2,876 couples undergoing assisted reproductive techniques (ART) such as in vitro fertilization.  Most men in these studies had reduced sperm counts and motility.  Scientists included randomized controlled trials comparing any type or dose of antioxidant supplement (single or combined) with placebo, no treatment, or another antioxidant, and taken by the male partner of a couple seeking fertility assistance. The outcomes were live birth, pregnancy, miscarriage, stillbirth, sperm DNA damage, sperm motility, sperm concentration, and adverse effects.

Antioxidant use was associated with a greater likelihood of pregnancy and live birth compared to a placebo or no treatment.  Improvements in sperm motility and concentration were also observed in association with antioxidant use in trials that evaluated these effects.  No harmful effects associated with antioxidant treatment were noted.

Although more head-to-head comparisons are needed to understand whether any one antioxidant performs better than others, current evidence suggests that antioxidant supplementation in subfertile males may improve the outcomes of live birth and pregnancy rate for subfertile couples undergoing cycles of assisted reproductive treatment.

Showell MG, et al. Antioxidants for male subfertility. 2011. Cochrane Database Syst Rev 1:CD007411.

Dietary Zinc Reduces Risk of Death From Prostate Cancer

According to a new Swedish study, men with a higher intake of dietary zinc may reduce the risk of prostate-related death.

The mineral zinc is involved in numerous enzymes and many essential cellular functions, including health of the immune system and DNA repair. Although previous research supports a role for zinc in prostate carcinogenesis, epidemiologic data are currently inconsistent. Little to no data on cancer-specific survival and zinc intake has been reported.

In a recent study, researchers sought to determine whether dietary zinc, assessed near the time of prostate cancer diagnosis, is associated with an improvement in survival.

This population-based cohort consisted of 525 Swedish men less than 80 years of age with a diagnosis of prostate cancer made between 1989 and 1994. Study participants completed food-frequency questionnaires, and zinc intake was derived from nutrient databases. Deaths from prostate cancer as well as from all causes were documented through February 2009.

After an average follow-up of 6.4 years, 218 (42%) men died of prostate cancer and 257 (49%) died of other causes. Compared to the group with lowest zinc intakes, high dietary zinc intake was associated with a reduced risk of prostate cancer-specific mortality. The association was stronger in men with localized tumors. Zinc intake was not associated with mortality from other causes.

The results of this study suggest that high dietary intake of zinc is associated with lower prostate cancer-specific mortality after diagnosis, particularly in men with localized tumors.

Epstein MM, et al. Dietary zinc and prostate cancer survival in a Swedish cohort. 2011. Am J Clin Nutr 93(3):586-93.